Skip to main content
Atrás
Watch Compare

Adicet Bio, Inc.

Calidad de datos: 83%
ACET
NASDAQ Manufacturing Chemicals
$7.92
▲ $0.92 (13.14%)
6 months return
—
Momentum
Neutral
ROE
-96.33%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-96.33%
Below sector avg (-54.68%)
ROIC-72.15%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio5.62
Interest Coverage-3392.06

Valoración

PE (TTM|NTM)
-0.57 | -2.36
Above sector avg (-1.50)
P/B Ratio0.61
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -96.98 M

Price History

Tendencias Financieras

Precio Objetivo de Analistas

6 analistas
Buy
+569.2%
upside to target
Actual
$7.92
Consensus Target
$53.00
$18.00
Mín
$128.00
Máx
Pronóstico
P/E Futuro
-2.36
EPS Futuro
-$3.36
Ingresos Est.
31.86 M

Sorpresas de Ganancias

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$3.13 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -$4.96 -$5.44 -$4.64 -$2.94 — —
Estimate -$5.38 -$4.75 -$5.07 -$2.99 -$3.13 -$2.16
Sorpresa +7.74% -14.61% +8.42% +1.59% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -96.33% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -116.80 M
ROE -96.33% ROA -76.98%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -96.98 M
ROIC -72.15% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 5.62
Debt / Equity N/A Current Ratio 5.62
Interest Coverage -3392.06 Asset Turnover N/A
Working Capital 87.55 M Tangible Book Value 109.14 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.57 · EV/EBITDA: N/A
P/E Ratio -0.57 Forward P/E -2.36
P/B Ratio 0.61 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2.08 Fwd Earnings Yield N/A
FCF Yield -146.41%
Market Cap 66.24 M Enterprise Value 37.14 M

Per Share

EPS: -16.95 · FCF/Share: -10.10
EPS (Diluted TTM) -16.95 Revenue / Share N/A
FCF / Share -10.10 OCF / Share -9.92
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 83.03% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 83.03%
SBC-Adj. FCF -112.38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -116.80 M -117.12 M -142.66 M -69.79 M -62.00 M
EPS (Diluted) -16.95 -1.33 -3.31 -1.70 —
Gross Profit — — — — —
Operating Income -122.11 M -127.62 M -152.04 M -72.55 M -61.43 M
EBITDA — — — — —
R&D Expenses 99.13 M 99.32 M 106.04 M 71.25 M 48.94 M
SG&A Expenses — — — — —
D&A 6.38 M 6.47 M 6.10 M 2.58 M 1.54 M
Interest Expense 36,000.0 4,000.0 25,000.0 80,000.0 176,000.0
Income Tax 0.0 0.0 0.0 0.0 -125,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 192.36 M 220.22 M 207.30 M 330.69 M 338.94 M
Total Liabilities 33.15 M 33.61 M 37.12 M 38.35 M 35.81 M
Shareholders' Equity 159.21 M 186.61 M 170.18 M 292.34 M 303.13 M
Total Debt — — — — —
Cash & Equivalents 38.92 M 56.50 M 159.71 M 257.66 M 277.54 M
Current Assets 160.93 M 180.14 M 162.27 M 261.04 M 282.44 M
Current Liabilities 21.53 M 19.39 M 19.29 M 19.71 M 16.32 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.6 -1.5
P/B 0.6 1.6
ROE % -96.3 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

ETFs Holding This Stock
CNCR CNCR
1.06% weight
BRUSX BRUSX
0.47% weight
BRSIX BRSIX
0.07% weight